Navigation Links
Stripping leukemia-initiating cells of their 'invisibility cloak'
Date:7/23/2009

Two new studies reveal a way to increase the body's appetite for gobbling up the cancer stem cells responsible for acute myeloid leukemia (AML), a form of cancer with a particularly poor survival rate. The key is targeting a protein on the surface of those cells that sends a "don't eat me" signal to the macrophage immune cells that serve as a first line of defense, according to the reports in the July 24th issue of the journal Cell, a Cell Press publication.

In essence, says Irving Weissman of Stanford University, that signal sent by a cell-surface protein known as CD47 "is an invisibility cloak for leukemia stem cells." Safe from the macrophages whose job it is to clear pathogens and damaged or aging cells from the bloodstream, the CD47-coated leukemia-producing cells are free to traverse the circulation, navigating macrophage-lined blood vessels of the spleen, liver and marrow, and lodging tumors along the way.

The same signal is also temporarily produced at lower levels by normal blood-forming stem cells when they migrate, said Siddhartha Jaiswal, also of Stanford. "CD47 is the vehicle that allows normal stem cells to move from one bone marrow site to another," he explained. To do that, they too must pass a field of macrophages.

"It's something protective on normal cells that's acquired by these malignant cells," Weissman said. The leukemia stem cells co-opt this ability and take it to an extreme in order to evade macrophage killing.

With their colleagues Ravindra Majeti and Mark Chao at Stanford, the researchers further extended their initial findings in mice to humans in the second study. They found that CD47 is more highly expressed on human acute myeloid leukemia stem cells than on their normal stem cell counterparts. Among adult patients with AML, higher CD47 levels predicted worse overall survival, they report.

Antibodies against CD47 allowed the cancer stem cells to be eaten by macrophages and preve
'/>"/>

Contact: Cathleen Genova
cgenova@cell.com
617-397-2802
Cell Press
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Medical Malpractice Survivors Decry Possible Stripping of Rights in Presidents Health Care Plan
2. Arsenic-based therapy shown to help eradicate leukemia-initiating cells
3. Tumors use enzyme to recruit regulatory T-cells and suppress immune response
4. Brain cells work differently than previously thought
5. Embryonic Stem Cells Repair Human Heart
6. Embryonic Human Stem Cells May Help Repair Heart Muscle, Lab Study Shows
7. Circulating fats kill transplanted pancreas cells, study shows
8. Experimental anti-cancer drug made from corn lillies kills brain tumor stem cells
9. Melanoma drug revs immune cells but cancer cells ignore it
10. Scientists explain how insulin secreting cells maintain their glucose sensitivity
11. Embryonic stem cells used to grow cartilage

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...as too short to draw definite conclusions, experts... News) -- In diabetic patients with blocked corona...outcomes at one year whether patients undergo bypa...esearchers report. , Bypass surgery has been th...ronary artery disease. However, less invasive appr...
(Date:11/25/2009)...ees few signs of trouble with the H1N1 vaccine, ,...- The ongoing H1N1 swine flu pandemic may be drivi...unger patients, a U.S. health official said Wednes...eumococcal infections around the country," Dr. Ann...munization and Respiratory Diseases at the U.S. Ce...
(Date:11/25/2009)...ectal cancer also can reverse a rare stomach disor...r the disease, researchers at Vanderbilt Universit...sease causes thickening of the stomach lining, sev...s anemia and swelling in the feet and ankles due t... gastric cancer. Previously, the only effective tr...
(Date:11/25/2009)...itiative expands to include cost-effective, sustai...d healthcare professionals in developing world. ,...vember 25, 2009 -- Elluminate, Inc. , the leader ...ons that support 21st century teaching, learning,... and Ice initiative was awarded iNACOL,s first-e...
(Date:11/25/2009)...PRNewswire/--dazzlesmile,llc www.dazzlesmile.com a...e.com havefileda67-pagefederallawsuitagainstEpicAd...lms,FarendServicesLimited,andAtLastFulfillment.The...CourtfortheDistrictofUtah,allegesmassivenationalco...teethwhiteningproducts,violationsoftheRacketeering...
Breaking Medicine News(10 mins):Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 2Health News:Swine Flu Tied to Rise in Pneumonias Among Young 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 4Health News:Vanderbilt scientists report first effective medical therapy for rare stomach disorder 2Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 2Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 3Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 4Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 5Health News:dazzlesmile Sues Epic Advertising and Jesse Willms 2
...y as it is better than sequential planning of with...ing can be easily quit// if a decision is taking i...e fruitful sometime. But the researchers at Un...ed suddenly succeeded for at least six months, com...
...s now medical colleges all set to shock parents of...ctors//. This goes for people based in Karnatak...remely high for 2006-07 session. The respite co.... The college which quoted the highest annual fee...
...Bio beer which contains various herbs and vitamins...takers, as the new beer does not increase obesity ... The beer, invented by Srinivasa Amarnath over 10...and hops. The vitamin-rich beer is five perc...
...t Therapy Unit of the University of Navarra's Ana ...nducting basic research by the Danone Institute. T...n a program// aimed at defining individualized tre...hormonal and metabolic response of women who are o...
...regard to a massive study concerning the bird flu ...t the St. Jude Children's Research Hospital. This ...egarding the proteins// and genes of these viruse... effects on the human race. The Infectious Disease...
...iversity of Pittsburgh said that they have genetic...contains the components of the deadly strain H5N1....ete protection to mice and chickens from infection...d in cells and very easily produced in large amoun...
Other Medicine News:Health News:Vaccine to protect birds against avian flu, engineered 2
(Date:11/25/2009)...RK,Nov.25/PRNewswire/--Reportlinker.comannouncesth...e: ,, IntranasalDrugDelivery-USMarketTrends&am...ntranasal-Drug-Delivery---US-Market-Trends--Analys...witnessinganexpansionoftherapeuticapplicationsfrom...edeliveryofsystemictherapeuticdrugs.Thefutureofthe...
(Date:11/25/2009)...AINVIEW,Calif.,Nov.25/PRNewswire/-- ChemoCentryx,...theCompany,sPROTECT-1(theProspectiveRandomizedOral...EN(TM)(CCX282-B)inpatientswithmoderate-to-severeCr...ablesafetyandtolerabilityprofile.Thestudydemonstra...seseverityasdefinedasa70-pointdecreaseintheCrohn,s...
(Date:11/24/2009)...E,Calif.,Nov.24/PRNewswire-FirstCall/--Endologix,I...atmentsforaorticdisorders,announcedtodaythatithasf...epatentinfringementlawsuitbroughtagainstitinOctobe...DistrictCourtinIndianapolis,Indiana. ,, Endolog...tedStatesPatentandTrademarkOffice(USPTO)conductspr...
Breaking Medicine Technology:Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2Reportlinker Adds Novo Nordisk A S 3A PharmaVitae Profile 58967 1Reportlinker Adds Novo Nordisk A S 3A PharmaVitae Profile 58967 2Reportlinker Adds Novo Nordisk A S 3A PharmaVitae Profile 58967 3Reportlinker Adds Novo Nordisk A S 3A PharmaVitae Profile 58967 4Reportlinker Adds Novo Nordisk A S 3A PharmaVitae Profile 58967 5Autism Stats Exaggerated 3A Parents Pushing Back This Weekend 58962 1Autism Stats Exaggerated 3A Parents Pushing Back This Weekend 58962 2Integrated Benefits Institute Announces Availability of 2008 IBI Benchmarking Industry Reports 58957 1Integrated Benefits Institute Announces Availability of 2008 IBI Benchmarking Industry Reports 58957 2Integrated Benefits Institute Announces Availability of 2008 IBI Benchmarking Industry Reports 58957 3
...utics,Inc. (CTI) (Nasdaq: CTIC ; MTA) today annou... accepted for review CTI,s Marketing Authorization...glumex, CT-2103) for,first-line treatment of patie...COG (Eastern Cooperative Oncology Group) performan...ginning of March. The validation of the MAA,for XY...
...ics, Inc.,(Nasdaq: CVTX ) today announced new dat... of the American College of Cardiology shows that,...gnificantly reduced the,risk of recurrent ischemia...fication of antianginal therapy (p=0.009) in angin..., Additionally, Ranexa significantly improved all...
Other Medicine Technology:European Regulatory Agency Accepts Cell Therapeutics, Inc.'s Marketing Authorization Application for XYOTAX(TM) for Lung Cancer for Review 2European Regulatory Agency Accepts Cell Therapeutics, Inc.'s Marketing Authorization Application for XYOTAX(TM) for Lung Cancer for Review 3European Regulatory Agency Accepts Cell Therapeutics, Inc.'s Marketing Authorization Application for XYOTAX(TM) for Lung Cancer for Review 4CV Therapeutics' Anti-Ischemic Therapy Ranexa(R) Significantly Reduces Cardiac Chest Pain Symptoms and Recurrent Ischemia in MERLIN-TIMI 36 Patients With Angina 2CV Therapeutics' Anti-Ischemic Therapy Ranexa(R) Significantly Reduces Cardiac Chest Pain Symptoms and Recurrent Ischemia in MERLIN-TIMI 36 Patients With Angina 3
Mosaic
...a Windows 2000 PC based EEG with high performance ...are. EEG-9200 provides high quality performance fr...ep lab or EEG lab. Quality EEG recording is assure...ax has high performance, high sensitivity amplifie...
Neuropack MEB-9100 Series
X-SIZER Catheter System
Medicine Products: